Cx Precision Medicine

Developing first blood-based diagnostic screening test for early assessment and treatment of Alzheimer’s, Parkinson’s and other neurodegenerative diseases.

[Opus Biotech Comm @Opus_Biotech]

@Opus_Biotech is pleased to partner with @CxPrecisionM, a biotech company developing blood-based diagnostics for early assessment and treatment of neurodegenerative diseases such as Alzheimer’s and Parkinson’s. https://t.co/kvjZ22OtZw #Alzheimers #Parkinsons